APA (7th ed.) Citation

SD, M., CF, L., L, B., S, W., A, K., M, B., & H, C. (2026). Pulmonary safety of Staccato alprazolam in healthy participants and participants with mild asthma: Phase 1, randomized, double-blind, placebo-controlled trial. Pulmonary pharmacology & therapeutics, 93, 102411. https://doi.org/10.1016/j.pupt.2026.102411

Chicago Style (17th ed.) Citation

SD, Miller, LaForce CF, Barlow L, Watanabe S, King A, Burian M, and Chanteux H. "Pulmonary Safety of Staccato Alprazolam in Healthy Participants and Participants with Mild Asthma: Phase 1, Randomized, Double-blind, Placebo-controlled Trial." Pulmonary Pharmacology & Therapeutics 93 (2026): 102411. https://doi.org/10.1016/j.pupt.2026.102411.

MLA (9th ed.) Citation

SD, Miller, et al. "Pulmonary Safety of Staccato Alprazolam in Healthy Participants and Participants with Mild Asthma: Phase 1, Randomized, Double-blind, Placebo-controlled Trial." Pulmonary Pharmacology & Therapeutics, vol. 93, 2026, p. 102411, https://doi.org/10.1016/j.pupt.2026.102411.